title: [Two particular aspects of Rhodococcus equi infection: malacoplakia and acquisition of resistance to antibiotics].
authors.forename: E
authors.initials: E
authors.lastname: Rouveix
authors.forename: C
authors.initials: C
authors.lastname: Dupont
authors.forename: P
authors.initials: P
authors.lastname: Ichai
authors.forename: M H
authors.initials: MH
authors.lastname: Nicolas
authors.forename: C
authors.initials: C
authors.lastname: Julie
authors.forename: G
authors.initials: G
authors.lastname: Lesur
authors.forename: M
authors.initials: M
authors.lastname: Dorra
mesh_terms: D042462:4-Quinolones; D000193:Actinomycetales Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008287:Malacoplakia / Q000382:microbiology*; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D016929:Rhodococcus equi / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D042462:4-Quinolones; D000890:Anti-Infective Agents; D012293:Rifampin